Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2009 1
2010 3
2012 5
2013 3
2014 1
2015 3
2016 3
2017 7
2018 13
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability.
Galanos P, Pappas G, Polyzos A, Kotsinas A, Svolaki I, Giakoumakis NN, Glytsou C, Pateras IS, Swain U, Souliotis VL, Georgakilas AG, Geacintov N, Scorrano L, Lukas C, Lukas J, Livneh Z, Lygerou Z, Chowdhury D, Sørensen CS, Bartek J, Gorgoulis VG. Galanos P, et al. Among authors: Pateras IS. Genome Biol. 2018 Mar 16;19(1):37. doi: 10.1186/s13059-018-1401-9. Genome Biol. 2018. PMID: 29548335 Free PMC article.
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth.
Pappas AG, Magkouta S, Pateras IS, Skianis I, Moschos C, Vazakidou ME, Psarra K, Gorgoulis VG, Kalomenidis I. Pappas AG, et al. Among authors: Pateras IS. Oncoimmunology. 2018 Nov 2;8(2):e1537427. doi: 10.1080/2162402X.2018.1537427. eCollection 2019. Oncoimmunology. 2018. PMID: 30713792 Free PMC article.
Geminin ablation in vivo enhances tumorigenesis through increased genomic instability.
Champeris Tsaniras S, Villiou M, Giannou AD, Nikou S, Petropoulos M, Pateras IS, Tserou P, Karousi F, Lalioti ME, Gorgoulis VG, Patmanidi AL, Stathopoulos GT, Bravou V, Lygerou Z, Taraviras S. Champeris Tsaniras S, et al. Among authors: Pateras IS. J Pathol. 2018 Oct;246(2):134-140. doi: 10.1002/path.5128. Epub 2018 Aug 21. J Pathol. 2018. PMID: 29952003
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.
Furth N, Pateras IS, Rotkopf R, Vlachou V, Rivkin I, Schmitt I, Bakaev D, Gershoni A, Ainbinder E, Leshkowitz D, Johnson RL, Gorgoulis VG, Oren M, Aylon Y. Furth N, et al. Among authors: Pateras IS. Life Sci Alliance. 2018 Oct 30;1(5):e201800171. doi: 10.26508/lsa.201800171. eCollection 2018 Oct. Life Sci Alliance. 2018. PMID: 30456386 Free PMC article.
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.
Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, Gorgoulis VG, Oren M. Cooks T, et al. Among authors: Pateras IS. Cancer Cell. 2013 May 13;23(5):634-46. doi: 10.1016/j.ccr.2013.03.022. Cancer Cell. 2013. PMID: 23680148 Free PMC article.
MiR-signing gastrointestinal (con-)tract cancer.
Gorgoulis VG, Pateras IS, Kotsinas A. Gorgoulis VG, et al. Among authors: Pateras IS. Oncotarget. 2017 May 2;8(18):29536-29537. doi: 10.18632/oncotarget.15701. Oncotarget. 2017. PMID: 28427154 Free PMC article. No abstract available.
Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, Gorgoulis VG, Rotter V. Solomon H, et al. Among authors: Pateras IS. Oncogene. 2018 Mar;37(12):1669-1684. doi: 10.1038/s41388-017-0060-8. Epub 2018 Jan 18. Oncogene. 2018. PMID: 29343849 Free PMC article.
47 results
Jump to page
Feedback